Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.57 | N/A |
| PEG Ratio (TTM) | 2.11 | N/A |
| P/S Ratio (TTM) | 1.85 | N/A |
| P/B Ratio (TTM) | 4.33 | N/A |
| P/FCF Ratio (TTM) | 20.72 | N/A |
| Price to 5YR AVG Earnings Ratio | 25.19 | N/A |
| Price to 5YR AVG FCF Ratio | 23.19 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.80% | N/A |
| ROE (TTM) | 28.27% | N/A |
| Net Profit Margin (TTM) | 11.15% | N/A |
| ROIC 5YR AVG | 48.51% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 60.83% | 74.08% | 50.70% |
| Revenue | 6.14% | 22.02% | 16.62% |
| Net Income | 58.49% | 77.56% | 52.86% |
| Cash Flow | 35.43% | 70.35% | 72.66% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.58 | N/A |
| Quick Ratio (TTM) | 1.45 | N/A |
| D/E Ratio (TTM) | 0.10 | N/A |
| Interest Coverage (TTM) | 139.21 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 7.20 | N/A |
| LTL to 5YR AVG FCF | 1.08 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.20% | N/A |